Need a new search?

If you didn't find what you were looking for, try a new search!

The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry

By |2016-02-02T08:30:03-08:00February 2nd, 2016|, |

Editor's Note:  The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry  - Michael E. Thase, MD

Comments Off on The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry

Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder

By |2016-02-02T03:32:40-08:00February 2nd, 2016|, |

Jodi M. Gonzalez, PhD ORIGINAL RESEARCH Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder Jodi M. Gonzalez, PhD, Peter Thompson, MD, Michael Escamilla, MD, Mako Araga, MS, Vivek Singh, MD, Niamh Farrelly, MD, Michael E. Thase, MD, [...]

Comments Off on Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder

U.S. Task Force Recommends All Adults Should be Screened For Depression

By |2016-01-26T16:36:55-08:00January 26th, 2016|We Know Psychiatry|

Screening of Pregnant Women and New Mothers a Priority January 26, 2016. CNN reports this morning that if new recommendations by the U.S. Preventive Services Task Force are followed, primary care physicians will do this type of depression screening for all adult patients at least once. The recommendations by the task [...]

Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia

By |2016-01-23T17:51:42-08:00January 23rd, 2016|We Know Psychiatry|

Abstract Many studies indicate a crucial role for the vitamin B12 and folate-dependent enzyme methionine synthase (MS) in brain development and function, but vitamin B12 status in the brain across the lifespan has not been previously investigated. Vitamin B12 (cobalamin, Cbl) exists in multiple forms, including methylcobalamin (MeCbl) and adenosylcobalamin [...]

Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy

By |2017-12-21T00:07:16-08:00January 11th, 2016|, |

EVIDENCE-BASED MEDICINE Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy By Michael E. Thase, MD

Comments Off on Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy

Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data

By |2017-12-21T00:07:09-08:00January 11th, 2016|, |

ORIGINAL RESEARCH Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data By Mark A. Demitrack, Michael E. Thase

Comments Off on Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data

Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?

By |2017-12-21T00:07:05-08:00January 11th, 2016|, |

EVIDENCE-BASED MEDICINE Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior? Alan G. Mallinger, Ellen Frank, Michael E. Thase, Michelle M. Barwell, Nancy DiazGranados, David A. Luck

Comments Off on Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?

Psychiatric Publisher Goes Digital

By |2015-12-31T17:17:29-08:00December 31st, 2015|We Know Psychiatry|

For Immediate Release December 31, 2015. Los Angeles CA Contact: James La Rossa Jr., 310.374.1300 MedWorks Media Inc., established in 1994 as one of the largest publishers of journals and educational medical projects about psychiatric medicine, was reconfigured for a 2016 launch as a cutting-edge digital portal and publisher — [...]

Joyce E. Myers, MD: Risperidone: Review of Its Therapeutic Utility in Depression

By |2015-12-19T01:18:54-08:00December 19th, 2015|, |

Joyce E. Myers, MD GENERAL PSYCHOPHARMACOLOGY Review of Its Therapeutic Utility in Depression Joyce E. Myers, MD, and Michael E. Thase, MD

Comments Off on Joyce E. Myers, MD: Risperidone: Review of Its Therapeutic Utility in Depression

Ripu D. Jindal, MD: Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression

By |2015-12-18T00:54:57-08:00December 18th, 2015|, |

Ripu D. Jindal, MD GENERAL PSYCHOPHARMACOLOGY Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression Ripu D. Jindal, MD, Amy L. Fasiczka, MA, Jonathan M. Himmelhoch, MD, Alan G. Mallinger, MD, and Michael E. Thase, MD

Comments Off on Ripu D. Jindal, MD: Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression

Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors

By |2015-12-17T20:34:32-08:00December 17th, 2015|, |

Mikael Landén, MD, PhD GENERAL PSYCHOPHARMACOLOGY A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors Mikael Landén, MD, PhD, and Michael E. Thase, MD

Comments Off on Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors

Mark S. Bauer, MD: Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide

By |2015-12-17T19:39:16-08:00December 17th, 2015|, |

Mark S. Bauer, MD ORIGINAL RESEARCH Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide Mark S. Bauer, MD, Stephen R. Wisniewski, PhD, Jane N. Kogan, PhD, Lauren B. Marangell, MD, Michael E. Thase, MD, Gary Sachs, MD, for the STEP-BD Investigators

Comments Off on Mark S. Bauer, MD: Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide

Gender-Specific Differences in Depression and Treatment Response

By |2017-12-21T00:00:25-08:00December 16th, 2015||

Gender-Specific Differences in Depression and Treatment Response By Susan G. Kornstein, MD, Diane M. E. Sloan, PharmD, and Michael E. Thase, MD

Comments Off on Gender-Specific Differences in Depression and Treatment Response

Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder

By |2017-12-21T00:00:08-08:00December 16th, 2015||

Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder By Michael E. Thase, MD, and Madhukar Trivedi, MD

Comments Off on Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
Go to Top